References
- Teranishi M, Naganawa S, Katayama M, Sugiura M, Nakashima T. Image evaluation of endolympahtic space in fluctuating hearing loss without vertigo. Eur Arch Otorhinolaryngol 2009;266:1871–7.
- Tagaya M, Teranishi M, Naganawa S, Iwata T, Yoshida T, Nakashima T. 3-Tesla magnetic resonance imaging obtained four hours after intravenous gadolinium injection in patients with sudden deafness. Acta Otolaryngol 2010;130:665–9.
- Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H. Visualization of endolymphatic hydrops in patients with Ménière's disease. Laryngoscope 2007;117:415–20.
- Naganawa S, Sugiura M, Kawamura M, Hukatsu H, Sone M, Nakashima T. Imaging of endolymphatic and perilymphatic fluid at 3T after intratympanic administration of gadolinium-diethylenetriamine pentaacetic acid. AJNR 2008;29:724–6.
- Rowley HA, Scialfa G, Gao P, Maldjian JA, Hassell D, Kuhn MJ, Contrast-enhanced MR imaging of brain lesions: a large scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide. AJNR 2008;29:1684–91.
- Kakigi A, Nishimura M, Takeda T, Okada T, Murata Y, Ogawa Y. Effects of gadolinium injected into the middle ear on the stria vascularis. Acta Otolaryngol 2008;128:841–5.
- Naganawa S, Nakashima T. Cutting edge of inner ear MRI. Acta Otolaryngol Suppl 2009;560:5–8.
- Tweedle MF. Physicochemical properties of Gadteridol and other magnetic resonance contrast agents. Invest Radiol Suppl 1992;1:2–6.
- Morisetti A, Bussi S, Tirone P, de Haën C. Toxicological safety evaluation of gadobenate dimeglumine 0.5M solution for injection (MultiHance), a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 1999;(Suppl 1):207–17.
- Elmståhl B, Nyman U, Leander P, Chai CM, Golman K, Björk J, Gadolinium contrast media are more nephrotoxic than iodine media. The importance of osmolality in direct renal artery injections. Eur Radiol 2006;16:2712–20.
- Mikulec AA, Hartsock JJ, Salt AN. Permeability of the round window membrane is influenced by the composition of applied drug solutions and by common surgical procedures. Otol Neurotol 2008;29:1020–6.
- Sahni RS, Paparella MM, Schachern PA, Goycoolea MV, Le CT. Thickness of the human round window membrane in different forms of otitis media. Arch Otolaryngol Head Neck Surg 1987;113:630–4.
- Yoshioka M, Naganawa S, Sone M, Nakata S, Teranishi M, Nakashima T. Individual differences in permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear. Otol Neurotol 2009;30:645–8.
- Mikulec AA, Plontke SK, Hartsock JJ, Salt AN. Entry of substances into perilymph through the bone of the otic capsule after intratympanic applications in guinea pigs: implications for local drug delivery in humans. Otol Neurotol 2009;30:131–8.
- Pyykkö I, Zou J, Poe D, Nakashima T, Naganawa S. Magnetic resonance imaging of the inner ear in Ménière's disease. Otolaryngol Clin North Am 2010;43:1059–80.
- Altun E, Martin DR, Wertman R, Lugo-Somolinos A, Fuller ER 3rd, Semelka RC. Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy – report from two U.S. universities. Radiology 2009;253:689–96.